Hamps Bio IPO listing price is ₹ 101.74, issue price is ₹ 51.00, and currently trading at ₹ 43.00 as on June 11, 2025. Hamps Bio IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Hamps Bio IPO is a Fixed Price listing on BSE SME exchange. The company is based in Bharuch and caters to Pharmaceutical sector. Marwadi Chandarana Intermediaries Brokers is the merchant banker of Hamps Bio IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th July 2024.
Hamps Bio IPO offer price is ₹ 51.00 and got listed at ₹ 101.74. Read Hamps Bio IPO details mentioned above.The IPO of Hamps Bio Limited was listed on 20th December 2024. As of today, Hamps Bio IPO is trading at ₹ 43.00, compared to the previous day’s close of ₹ 42.84. Read the report above for detailed IPO performance.
The issue price of Hamps Bio IPO was ₹ 51.00 per equity share.
Hamps Bio IPO was listed at ₹101.74 on the stock exchange on 20th December 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 11, 2025, the current market price of Hamps Bio IPO is ₹ 43.00.
The 52-week high for Hamps Bio IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Hamps Bio IPO listed at ₹ 101.74 against the issue price of ₹ 51.00 per equity share, showing a listing day gain/loss of 50.74 (99.49%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Hamps Bio IPO stock moved from its listing price of ₹ 101.74 to the current price of ₹43.00 per equity share, reflecting a change of -57.74% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Hamps Bio IPO issue date of 20th December 2024 and CMP of ₹43.00, the estimated CAGR is approximately -29.66%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Hamps Bio IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Hamps Bio Financial Review Page
Merchant Banker(s) of Hamps Bio IPO: Marwadi Chandarana Intermediaries Brokers Private Limited
Hamps Bio IPO subscription was 1057.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Hamps Bio IPO listed at a listing price of 101.74 against the offer price of 51.00.
The current market price of Hamps Bio is 43.00.
Why Us?